Robert Alan Nagourney MD
Hematologic Oncology
Founder & Medical Director of Rational Therapeutics
Join to view full profile
701 E 28th StLong Beach, CA 90806
Phone+1 562-989-6455
Fax+1 562-989-8160
Dr. Nagourney is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 1984 - 1985
MedStart Georgetown University HospitalFellowship, Medical Oncology, 1982 - 1984
University of California (Irvine)Residency, Internal Medicine, 1980 - 1982
McGill University Faculty of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1980 - 2027
VA State Medical License 1983 - 2022
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification GeniusDoc, GeniusDoc, Inc., 2013-2017
- CMS Meaningful Use Stage 1 Certification GeniusDoc EHR, GeniusDoc, Inc., 2013-2017
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities.Sabina A Schneider, Paulo D'Amora, Steven S Evans, Paul Kent, Tom Stockwell
Cancers. 2026-05-27 - 1 citationsSerial Functional and Genomic Analyses Illuminate Clonal Evolution in Metastatic NSCLC with 12-Year Survival.Vikrant S Bakaya, Sabina A Schneider, Tracy Nguyen, Derrick C Phu, Lucas A Alvarez
Current Oncology. 2025-11-19 - 3 citationsDiagnostic and Prognostic Performance of Metabolic Signatures in Pancreatic Ductal Adenocarcinoma: The Clinical Application of Quantitative NextGen Mass Spectrometry.Paulo D'Amora, Ismael D C G Silva, Steven S Evans, Adam J Nagourney, Katharine A Kirby
Metabolites. 2024-02-29
Press Mentions
The Promise of Metabolomics to Transform Breast Cancer ScreeningJanuary 13th, 2025- Blood Test Could Identify Severity of SARS-CoV-2 Infections, Researchers SayDecember 12th, 2021
- Radiation from Wireless Devices May Cause Breast Cancer, New Study ShowsDecember 17th, 2020
Grant Support
- Detection And Circumvention Of Drug ResistanceNational Cancer Institute1986
Professional Memberships
- Member
External Links
- Rational Therapeuticshttp://www.rational-t.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
